| Infiltrative cardiomyopathy (n = 11) | HCM (n = 30) | p value |
---|---|---|---|
Age*, years | 68 ± 11 | 62 ± 11 | 0.059 |
Gender: men, n (%) | 8 (73Â %) | 13 (43Â %) | 0.095 |
Hs-cTnT*, ng/ml | 0.083 ± 0.057 | 0.025 ± 0.031 | <0.001 |
BNP*, pg/ml | 349 ± 301 | 248 ± 203 | 0.332 |
eGFR, ml/min per 1.73 m2 | 61 ± 17 | 69 ± 19 | 0.220 |
NYHA functional class, n (%) | Â | Â | 0.124 |
 I | 2 (18 %) | 16 (53 %) |  |
 II | 8 (73 %) | 13 (43 %) |  |
 III | 1 (9 %) | 1 (3 %) |  |
Hx. of heart failure admission, n (%) | 5 (45Â %) | 6 (20Â %) | 0.111 |
Maximum LV wall thickness, mm | 17 ± 3 | 20 ± 4 | 0.029 |
Interventricular wall thickness, mm | 16 ± 3 | 16 ± 4 | 0.562 |
Posterior wall thickness*, mm | 15 ± 3 | 10 ± 2 | <0.001 |
LV end-diastolic diameter, mm | 44 ± 5 | 45 ± 6 | 0.877 |
LV end-systolic diameter*, mm | 32 ± 7 | 28 ± 8 | 0.161 |
Ejection fraction, % | 54 ± 13 | 61 ± 13 | 0.147 |
Left atrial diameter, mm | 44 ± 6 | 44 ± 9 | 0.950 |
E*, cm/s | 89 ± 23 | 69 ± 21 | 0.019 |
A, cm/s | 67 ± 33 | 67 ± 19 | 0.985 |
E/A* | 1.7 ± 1.0 | 1.1 ± 0.5 | 0.069 |
Dct*, msec | 208 ± 81 | 198 ± 70 | 0.825 |
Ea septal*, cm/s | 3.9 ± 1.1 | 5.0 ± 2.3 | 0.226 |
Ea lateral*, cm/s | 4.8 ± 1.3 | 7.9 ± 3.3 | <0.001 |
E/Ea septal | 24 ± 7 | 16 ± 7 | 0.002 |
E/Ea lateral* | 20 ± 8 | 10 ± 4 | <0.001 |
Presence of LVOTO, n (%) | 1 (9Â %) | 5 (17Â %) | 1.000 |
Presence of RVH, n (%) | 6 (55Â %) | 14 (47Â %) | 0.655 |